162 related articles for article (PubMed ID: 18756838)
1. IgA nephropathy: challenges and opportunities.
Glassock RJ
Cleve Clin J Med; 2008 Aug; 75(8):569-76. PubMed ID: 18756838
[TBL] [Abstract][Full Text] [Related]
2. [IgA nephropathy (immunoglobulin A nephropathy, M.Berger). Main symptoms: (painless) macrohematuria or microhematuria].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Oct; 93(44):1809-13; quiz 1814. PubMed ID: 15559904
[No Abstract] [Full Text] [Related]
3. [IgA nephropathy].
Alamartine E
Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
[TBL] [Abstract][Full Text] [Related]
4. Prognostic indicators and treatment of childhood IgA nephropathy.
Hogg RJ
Contrib Nephrol; 1995; 111():194-9; discussion 199-200. PubMed ID: 7758342
[No Abstract] [Full Text] [Related]
5. [IgA nephropathy--the most common form of glomerulonephritis].
Pettersson E
Duodecim; 1995; 111(15):1435-41. PubMed ID: 9244699
[No Abstract] [Full Text] [Related]
6. [Management of IgA nephropathy].
Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
[TBL] [Abstract][Full Text] [Related]
7. [IgA nephropathy - prognostic factors and treatment].
Wieliczko M; Dylewska M
Wiad Lek; 2016; 69(5):707-710. PubMed ID: 28033590
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A nephropathy and chronic kidney disease.
Tomino Y
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
[TBL] [Abstract][Full Text] [Related]
9. Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
Ramachandran R; Doddi P; Nandakrishna B; Nada R; Kumar V; Rathi M; Kohli HS; Jha V; Sakhuja V; Gupta KL
Int Urol Nephrol; 2015 Nov; 47(11):1917-8. PubMed ID: 26411427
[No Abstract] [Full Text] [Related]
10. Advanced IgA nephropathy: to treat or not to treat?
Locatelli F; Pozzi M; Del Vecchio L; Pozzi C
Nephron Clin Pract; 2003; 93(4):c119-21. PubMed ID: 12759578
[No Abstract] [Full Text] [Related]
11. [IgA nephropathy in children].
Gagnebin AL; Campiche M; Guignard JP
Rev Med Suisse Romande; 1994 Oct; 114(10):879-88. PubMed ID: 7973301
[No Abstract] [Full Text] [Related]
12. Quantitative appraisal of treatment options for IgA nephropathy.
Ballardie FW
J Am Soc Nephrol; 2007 Nov; 18(11):2806-9. PubMed ID: 17942959
[TBL] [Abstract][Full Text] [Related]
13. [Some problems should be mentioned in treating nephropathy].
Rao XR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):556-8. PubMed ID: 17633374
[No Abstract] [Full Text] [Related]
14. Immunoglobulin A Nephropathy and Immunoglobulin A Vasculitis.
Nicoara O; Twombley K
Pediatr Clin North Am; 2019 Feb; 66(1):101-110. PubMed ID: 30454736
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
16. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
Cheng G; Liu D; Margetts P; Liu L; Zhao Z; Liu Z; Tang L; Fang Y; Li H; Guo Y; Chen F; Liu F
Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
[TBL] [Abstract][Full Text] [Related]
17. The clinical course of IgA nephropathy after kidney transplantation and its management.
Lionaki S; Panagiotellis K; Melexopoulou C; Boletis JN
Transplant Rev (Orlando); 2017 Apr; 31(2):106-114. PubMed ID: 28209246
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists.
Schena FP
Am J Med; 2001 Apr; 110(6):499-500. PubMed ID: 11331065
[No Abstract] [Full Text] [Related]
20. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
